Global /China /Healthcare /Biotechnology /688046

GemPharmatech Co., Ltd.

688046

• SSE: 688046 • Delayed

20.60CNY -0.3%

3.04 USD

As of 21 June 2026, GemPharmatech Co., Ltd. has a market cap of $536.88M USD, ranking #14683 globally and #4572 in China. It ranks #1305 in the Healthcare sector, and #246 in the Biotechnology industry.

Global Rank

14683

Country Rank

4572

Sector Rank

1305

Industry Rank

246

Key Stats

Market Cap

$536.88MUSD

3.63B CNY

Enterprise Value

$1.12BUSD

7.6B CNY

Revenue (TTM)

$122.92MUSD

830.61M CNY

EBITDA (TTM)

$40.88MUSD

276.71M CNY

Net Income (TTM)

$23.64MUSD

159.76M CNY

EBITDA Margin

33%

Profit Margin

19%

PE Ratio

51.4

Forward PE

44.8

PS Ratio

10.2

PB Ratio

3.7

EV/EBITDA

27.3

Company Profile

Country (HQ)

China

Sector

Healthcare

Industry

Biotechnology

CEO

Jing Zhao open_in_new

Employees

1,578

Founded

2017

Website

gempharmatech.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-0.3%	5.4%	41%	18%	18%	34%	79%	-8.4%	-4.4%

News

Markets

Exchange	Ticker	Price	Quotes
Shanghai Stock Exchange (SSE / SHA) MIC: XSHG PRIMARY	688046 江苏集萃药康生物科技股份有限公司 Class A ISIN: CNE100005964 Shares Out.: Shares Outstanding: 202.383M¹ Shares Float: 79.289M² TV: TradingView: SSE: 688046 SA: Stock Analysis: SHA: 688046 YF: Yahoo Finance: 688046.SS GF: Google Finance: SHA: 688046 BA: Barron's: 688046 MS: Morningstar: XSHG: 688046	20.60 CNY	TV: TradingView: SSE: 688046 SA: Stock Analysis: SHA: 688046 YF: Yahoo Finance: 688046.SS GF: Google Finance: SHA: 688046 BA: Barron's: 688046 MS: Morningstar: XSHG: 688046

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About GemPharmatech Co., Ltd.

GemPharmatech Co., Ltd., a contract research organization, provides genetically engineered mouse models and preclinical research services to the scientific community worldwide. The company offers mouse models, including knockout and conditional knockout mouse, disease mouse, immunodeficient mouse, germ-free mouse, and tool mice models, as well as operates wild mouse project. It also provides custom model generation, preclinical testing, germ-free and microbiome, cell lines and customization, custom breeding, animal quality testing, and other services. The company has a strategic alliance with Memorial Sloan Kettering Cancer Center (MSK) to accelerate the discovery of new therapeutic antibodies. The company was founded in 2017 and is headquartered in Nanjing, China.

Similar Companies

Industry: Biotechnology (China)

Name	Market Cap (USD) diff.	PE	Country
WuXi Biologics (Cayman) Inc. SHEK: 2269	$17.44B 136.71B HKD 3K%	25.3	China
CSPC Pharmaceutical Group Ltd. SHEK: 1093	$12.19B 95.58B HKD 2K%	22.1	China
Sichuan Kelun Pharmaceutical Co., Ltd. SHE: 002422	$8.03B 54.23B CNY 1K%	34.4	China
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. SSE: 603392	$7.35B 49.69B CNY 1K%	-	China
3SBio Inc. SHEK: 1530	$7.08B 55.5B HKD 1K%	5.8	China
Hangzhou Tigermed Consulting Co., Ltd. SHE: 300347	$6.74B 45.52B CNY 1K%	61.6	China

Industry: Biotechnology (Global)

Name	Market Cap (USD) diff.	PE	Country
Amgen Inc. NASDAQ: AMGN	$182.42B 34K%	23.9	United States
Gilead Sciences, Inc. NASDAQ: GILD	$159.92B 30K%	19.0	United States
argenx SE EBR: ARGX	$47.43B 41.39B EUR 9K%	39.9	Netherlands
Samsung Biologics Co.,Ltd. KRX: 207940	$44.23B 68.19T KRW 8K%	35.5	South Korea
CSL Ltd. ASX: CSL	$42.27B 60.27B AUD 8K%	29.3	Australia
Lonza Group AG SIX: LONN	$41.88B 33.71B CHF 8K%	37.2	Switzerland

chevron_leftBack